Desvenlafaxine

Desvenlafaxine

SCHEMBL3345158

CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A4

The experimentally established mechanism targets of Desvenlafaxine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 9/20 0.97
SLC6A4 known ✓ P31645 9/20 0.97
SLC6A3 Q01959 5/20 0.97
OPRM1 P35372 1/20 0.97
LMNA P02545 1/20 0.70
CNR1 P21554 1/20 0.70
HTR2A P28223 1/20 0.70
HRH1 P35367 1/20 0.70
HRH3 Q9Y5N1 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Desvenlafaxine SCHEMBL4306707 0.98 SLC6A2 (0.97) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL4306704 0.98 SLC6A2 (0.97) SLC6A2SLC6A4SLC6A3OPRM1LMNA
SCHEMBL10772550 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL34864 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL34863 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL3277527 0.98 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL2053955 0.97 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Hydrochloric Acid SCHEMBL10491682 0.97 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Desvenlafaxine SCHEMBL623709 0.97 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA
Hydrochloric Acid SCHEMBL10772551 0.97 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3OPRM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677254-B1 SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DESVENLAFAXINE SANOVEL ILAC SANAYI VE TICARET AS (TR) 2023-10-25 EP claimed
EP-2252573-A2 NEW POLYMORPH AND AMORPHOUS FORMS OF DESVENLAFAXINE FUMARATE Egis Gyógyszergyár Nyilvánosan Müködö (HU) 2010-11-24 EP disclosed
EP-2252573-A2 NEW POLYMORPH AND AMORPHOUS FORMS OF DESVENLAFAXINE FUMARATE Egis Gyógyszergyár Nyilvánosan Müködö (HU) 2010-11-24 EP disclosed
WO-2009101458-A3 NEW POLYMORPH AND AMORPHOUS FORMS OF DESVENLAFAXINE FUMARATE EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ (HU) 2010-04-08 WO disclosed
WO-2009101458-A2 NEW POLYMORPH AND AMORPHOUS FORMS OF DESVENLAFAXINE FUMARATE EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ (HU) 2009-08-20 WO disclosed
WO-2009101458-A2 NEW POLYMORPH AND AMORPHOUS FORMS OF DESVENLAFAXINE FUMARATE EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ (HU) 2009-08-20 WO disclosed